Musculoskeletal diseases

NSAIDs fail to reduce joint inflammation for people with arthritis of the knee, study results show

Comparing two groups of people with synovitis, researchers found that those treated with long-term oral non-steroidal anti-inflammatory drugs had worse synovitis than those not treated with the drugs.…

‘Milestone’ as NICE recommends biologics in moderate rheumatoid arthritis for the first time

Updated guidance from the National Institute for Health and Care Excellence will increase access to advanced therapies adalimumab, etanercept and infliximab within the NHS.…

Draft NICE guidance recommends first biologics for treatment of moderate rheumatoid arthritis

Final draft guidance from the National Institute for Health and Care Excellence states that adalimumab, etanercept and infliximab are recommended in the treatment of moderate rheumatoid arthritis.…

Trial suggests JAK1 inhibitor is superior to methotrexate for treatment of early rheumatoid arthritis

A selective Janus kinase inhibitor, upadacitinib, is superior to methotrexate in improving clinical outcomes in patients with rheumatoid arthritis, a study has suggested.…

Secukinumab and adalimumab comparable for first-line psoriatic arthritis treatment

Biological therapies secukinumab and adalimumab are similarly effective at improving the musculoskeletal symptoms of psoriatic arthritis, a head-to-head trial suggests.…

The role of topical NSAIDs in the management of joint pain in the community

Download the full PDF of this white paper here.…

Supported content

Opioid use offers limited benefits for patients with osteoarthritis

Opioids offer only small benefits in terms of pain and function in osteoarthritis and do not improve quality of life or depression, research presented at the 2019 American College of Rheumatology annual meeting has suggested.…

Managing osteoporosis in older people

How to understand bone health in the context of the older person, including risk assessment, prevention and the management of osteoporosis in patients likely to have multiple comorbidities.…

Joint pain: pathology and treatment

An overview of joint pain for community pharmacy teams.…

Supported content

Pharmacy leaders must train and support teams to meet the needs of patients with joint pain

Community pharmacy has both a professional responsibility and commercial interest in ensuring pharmacy teams receive the necessary training and possess the appropriate knowledge to deliver the best person-centred care.…

Supported content